Condition
Drug Users
Total Trials
5
Recruiting
1
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 1 (1)
Trial Status
Completed4
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT02144415Phase 1Completed
A Study to Evaluate the Abuse Potential of EB-1020 Immediate-Release in Healthy Recreational Stimulant Users
NCT07117656Not ApplicableRecruiting
Project Vuselela Feasibility
NCT02971488Completed
The Impact on Linkage-to-care of an Alternative Hepatitis C Screening Method in PWID
NCT01343472Not ApplicableCompleted
Evaluation of the Washington Intensive Supervision Program
NCT01829308Not ApplicableCompleted
SBIRT Implementation for Adolescents in Urban Federally Qualified Health Centers
Showing all 5 trials